DexCom Inc DXCM Bullish Thesis Highlights Recurring Revenue Moat CatalystDriven Upside Amid Recent Pullback X4 Pharmaceuticals XFOR Stock Chart Pattern Insight X4 Pharmaceuticals posts 379 EPS beat with narrower loss IMDX Insight shares gain 1163 percent despite wide fourth quarter 2025 earnings miss against analyst consensus estimates